Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
暂无分享,去创建一个
T. Muchamuel | M. Bennett | F. Parlati | K. Shenk | S. Arastu‐Kapur | C. Kirk | M. Kraus | C. Driessen | A. J. Ball | J. Anderl | Susan J. Lee